Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)

Asociación Española para el Estudio del Hígado5,000 enrolled

Overview

The purpose of the registry is to know the status of primary biliary colgantis, autoimmune hepatitis, primary sclerosing cholagitis and genetic cholestatic diseases in Spain.

Study Type

OBSERVATIONAL

Enrollment

5,000

Conditions

Hepatitis Autoimmune Disease Primary Biliary Cholangitis (PBC)Primary Sclerosing Cholangitis (PSC)Cholestatic Genetic Diseases

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with a confirmed diagnosis for PBC, HAI, PSC, genetic cholestatic disease Exclusion Criteria: * Refusal to sign the informed consent for the study

Locations (1)

Hospital Clinic

Barcelona, Spain

RECRUITING

Outcomes

Primary Outcomes

Prevalence and characteristics of autoimmune and cholestatic liver disease in Spain

Evaluation of clinical characteristics of autoimmune and cholestatic liver diseases

Time frame: 2025

Secondary Outcomes

Development of liver-related events in autoimmune ahd cholestatic liver diseases

Time frame: 2025

Treatment of autoimmune and cholestatic liver diseases in Spain

Time frame: 2016-2030

Central Contacts

Asociación Española para el Estudio del Hígado Asociación Espa

CONTACT

0034915551119 registrocolhay@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.